Dermal Toxicity Testing Market - By Type (Product, Service), Testing Method (In Vivo, In Vitro, In Silico Modeling), Test Type (Skin Irritation, Sensitization, & Corrosion, Phototoxicity), End-use (Healthcare, Cosmetics)- Global Forecast 2023-2032

Description

List of Tables

Dermal Toxicity Testing Market size is poised to expand at 8.3% CAGR between 2023 and 2032 driven by the increasing focus on sustainable practices and the ongoing development of eco-friendly products. Of late, numerous eco-conscious consumers and brands are demanding products free of harmful chemicals. The strong focus on sustainable practices is contributing to the increasing adoption of dermal testing to ensure the quality of the ingredients.

Several governments are pushing sustainability with stricter regulations for mandating thorough dermal assessments for eco-friendly products. Moreover, regulatory bodies worldwide, such as REACH (EU) and FDA (US) are enacting stricter regulations for the safety of chemicals and cosmetics for thorough dermal toxicity testing before products can be marketed, adding to the industry expansion.

The dermal toxicity testing industry is segmented into type, testing method, test type, end-use, and region.

Based on type, the market share from the product segment is projected to gain significant traction at 8.4% CAGR from 2023-2032. The ongoing innovations in dermal toxicity testing products, such as sophisticated in vitro assays and advanced instrumentation, is helping to transform the landscape of toxicology assessment. These products offer more accurate, efficient, and humane alternatives to traditional animal testing methods to match the ethical and regulatory considerations. The increasing adoption of advanced dermal toxicity testing products by pharmaceutical, cosmetic, and chemical industries is also expected to fuel the segment expansion.

In terms of end-use, the dermal toxicity testing market from the cosmetics and personal care products segment generated substantial revenue in 2022 and is estimated to witness 7.8% CAGR between 2023 and 2032. The rising consumer demand for safe and gentle products is driving several brands to invest heavily in tests to ensure their formulations limit irritation, allergies, and systemic harm. Moreover, emerging trends like personalized beauty and natural ingredients are necessitating customized toxicity assessments, further creating lucrative opportunities for specialized testing labs.

Regionally, the Asia Pacific dermal toxicity testing industry is set to exhibit 8.9% growth rate through 2032 attributed to the presence of a booming cosmetics and personal care sector, particularly in China, India, and South Korea. Regulatory bodies across the region are implementing stricter safety standards for chemicals and cosmetics, supporting the regional market growth. To cite an instance, in February 2023, Gabon, Sri Lanka, and Jamaica joined forces to oppose harmful cosmetic practices, initiating a combined $14 million mission to eradicate the use of mercury in skin-lightening products.

Product Code: 7561

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & workings
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Primary
- 1.4.2 Secondary
  - 1.4.2.1 Paid sources
  - 1.4.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Global dermal toxicity testing market 360 degree synopsis, 2018 - 2032
- 2.1.1 Regional trends
- 2.1.2 Type trends
- 2.1.3 Testing method type trends
- 2.1.4 Test type trends
- 2.1.5 End-use trends

Chapter 3 Dermal Toxicity Testing Industry Insights

3.1 COVID- 19 impact analysis
3.2 Industry ecosystem analysis
3.3 Technology landscape
3.4 Regulatory landscape
3.5 Industry impact forces
- 3.5.1 Growth drivers
  - 3.5.1.1 Regulatory variability across the globe
  - 3.5.1.2 Advancements in technology
  - 3.5.1.3 Increasing awareness among consumers about product safety
  - 3.5.1.4 Shifting focus on sustainable practices
- 3.5.2 Industry pitfalls & challenges
  - 3.5.2.1 Lack of standardized protocols and methodologies for dermal toxicity testing
3.6 Growth potential analysis
- 3.6.1 By type
- 3.6.2 By testing method
- 3.6.3 By test type
- 3.6.4 By end-use
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
- 4.1.1 Charles River Laboratories
- 4.1.2 Eurofins Scientific
- 4.1.3 Qiagen N.V.
4.2 Competitive analysis of major market players, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic outlook matrix, 2022

Chapter 5 Dermal Toxicity Testing Market Size and Forecast, By Type, 2018-2032 (USD Million)

5.1 Key trends, by type
5.2 Product
5.3 Services
- 5.3.1 Inhouse services
- 5.3.2 Outsource services

Chapter 6 Dermal Toxicity Testing Market Size and Forecast, By Testing Method, 2018-2032 (USD Million)

6.1 Key trends, by testing method
6.2 In-vivo testing
6.3 In-vitro testing
6.4 In-silico modeling

Chapter 7 Dermal Toxicity Testing Market Size and Forecast, By Test Type, 2018-2032 (USD Million)

7.1 Key trends, by test type
7.2 Skin irritation tests
7.3 Skin sensitization tests
7.4 Skin corrosion tests
7.5 Phototoxicity tests

Chapter 8 Dermal Toxicity Testing Market Size and Forecast, By End-use, 2018-2032 (USD Million)

8.1 Key trends, by end-use
8.2 Healthcare industry
8.3 Cosmetics and personal care products industry
8.4 Chemical industry
8.5 Other end-users

Chapter 9 Dermal Toxicity Testing Market Size and Forecast, By Region, 2018-2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Italy
- 9.3.5 Spain
- 9.3.6 Russia
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 Thailand
- 9.4.6 Malaysia
- 9.4.7 Philippines
- 9.4.8 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 South Africa
- 9.6.3 UAE
- 9.6.4 Rest of Middle East & Africa

Chapter 10 Company Profiles

10.1 QIMA LTD
10.2 Charles River Laboratories
10.3 Evotec
10.4 MatTek Corporation
10.5 Eurofins Scientific
10.6 SGS Group
10.7 Intertek Group
10.8 InVivo Biosystems
10.9 Eurofins Scientific
10.10 Qiagen N.V.